Results 21 to 30 of about 355,053 (311)
The clinical features, diagnosis, and treatment of cognitive impairments in Parkinson's disease
Неврология, нейропсихиатрия, психосоматика, 2017 The review presents the data of recent studies dealing with cognitive impairments (CI) in patients with Parkinson's disease (PD) and gives their characteristics and epidemiology, the specific features of the pathogenesis and clinical manifestations, as ...
G. N. Akhmadeeva +3 more
doaj +1 more source
Botulinum Toxin in the Management of Children with Cerebral Palsy
Pediatric Drugs, 2019 During the past 25 years, botulinum toxin type A (BoNT-A) has become the most widely used medical intervention in children with cerebral palsy. In this review we consider the gaps in our knowledge in the use of BoNT-A and reasons why muscle morphology ...
Iqbal Multani +4 more
semanticscholar +1 more source
Mechanisms of Botulinum Toxin Type A Action on Pain
Toxins, 2019 Already a well-established treatment for different autonomic and movement disorders, the use of botulinum toxin type A (BoNT/A) in pain conditions is now continuously expanding.
I. Matak +3 more
semanticscholar +1 more source
Immunogenicity Associated with Botulinum Toxin Treatment
Toxins, 2019 Botulinum toxin (BoNT) has been used for the treatment of a variety of neurologic, medical and cosmetic conditions. Two serotypes, type A (BoNT-A) and type B (BoNT-B), are currently in clinical use. While considered safe and effective, their use has been
Steven T Bellows, J. Jankovic
semanticscholar +1 more source
Botulinum Toxin Injection for the Treatment of Upper Esophageal Sphincter Dysfunction
Toxins, 2022 Dysphagia associated with upper esophageal sphincter (UES) dysfunction remarkably affects the quality of life of patients. UES injection of botulinum toxin is an effective treatment for dysphagia. In comparison with skeletal muscles of the limb and trunk,
Pengxu Wei
doaj +1 more source
Annals of Movement Disorders, 2020 Objective: The aim was to assess the opinion of the movement disorder society of India members regarding the uses of botulinum toxin in clinical practice.
Ashwin K Panda, Sanjay Pandey
doaj +1 more source
Scientific Reports, 2021 The advanced biomimetic mineralization technology was applied to protect the Botulinum neurotoxin type D, and the processing of the mineralization granule of botulinum toxin type D was successfully screened.
Shengqing Li +6 more
doaj +1 more source
Tremor and Other Hyperkinetic Movements, 2012 Background: It is generally agreed that diffusion of botulinum toxin occurs, but the extent of the spread and its clinical importance are disputed. Many factors have been suggested to play a role but which have the most clinical relevance is a subject of much discussion.
Brodsky, Matthew A. +2 more
openaire +5 more sources
Cochrane systematic review and meta-analysis of botulinum toxin for the prevention of migraine
BMJ Open, 2019 Objectives To assess the effects of botulinum toxin for prevention of migraine in adults. Design Systematic review and meta-analysis. Data sources CENTRAL, MEDLINE, Embase and trial registries.
Clare P Herd +7 more
semanticscholar +1 more source
Botulinum toxin type A in treatment of chronic migraine, spasticity and bruxism
Journal of Education, Health and Sport, 2023 Introduction: Nowadays, botulinum toxin has found use in many disease entities such as chronic migraine, spasticity, bruxism and many others. Among serotypes A-E, type A is mainly used in treatment.
Klaudia Kuliga +9 more
doaj +1 more source